Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitolisant in Type 1 Diabetes
NCT04026750Phase 1Terminated
- Sponsor
- High Point Clinical Trials Center
- Start
- Sep 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in type 1 diabetes mellitus (T1D) comparing Pitolisant with Matching placebo (2 arms). Primary endpoint: Change From Baseline in Peak Glucagon Response to Hypoglycemia at Day 7. Started Sep 2019; status: terminated.
02
Drugs
pitolisant
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04026750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04026750.